Understanding How Regulatory Requirements Are Applied in Practice

Regulations and guidance establish expectations. Inspections show how those expectations are evaluated in the real world.

FDA inspection activity provides valuable insight into compliance performance, recurring deficiencies, agency priorities, and changes in regulatory oversight. Examined over time, inspection data can help regulated organizations better understand where compliance problems are occurring and where regulatory attention may be shifting.

MDP Inspection & Compliance Intelligence monitors inspection activity and related compliance information to identify patterns, emerging risks, and practical lessons for regulated organizations.

FDA Inspection Intelligence

FDA inspections can result in classifications ranging from No Action Indicated (NAI) to Voluntary Action Indicated (VAI) and Official Action Indicated (OAI). MDP examines inspection activity, outcomes, compliance programs, regulatory areas, and historical trends to provide context for what FDA inspection data are showing.

Medical Device & QMSR Compliance

FDA’s Quality Management System Regulation (QMSR) represents a significant change in medical device quality system oversight, incorporating ISO 13485:2016 by reference and changing the framework under which manufacturers are inspected.

MDP monitors QMSR implementation, inspection activity, compliance trends, and emerging observations to help manufacturers understand how the new framework is being applied in practice.

Compliance Trends

Inspection findings can reveal recurring weaknesses involving quality systems, manufacturing controls, documentation, data integrity, corrective and preventive action, supplier oversight, validation, and other areas of regulatory compliance.

Looking across inspections rather than at individual observations allows MDP to identify broader patterns that may provide early warning of developing compliance risks.

From Inspection Results to Regulatory Intelligence

An inspection tells us how one establishment performed at a particular point in time. Regulatory intelligence asks what inspection activity collectively tells us about the broader compliance environment.

By examining inspection volumes, classifications, observations, regulatory programs, industries, and historical trends, MDP seeks to identify changes in FDA oversight and the compliance issues regulated organizations should be watching.

As the MDP Regulatory Intelligence program grows, this page will connect to inspection analyses, QMSR intelligence, compliance trends, data visualizations, and other regulatory oversight research.

The inspection shows what FDA found. Intelligence comes from understanding what those findings reveal.